| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―May―07 |
Evaluation of the therapeutic action of original antiviral drug in SARS-CoV-2 |
Arthur K. Melkonian, Gagik V. Hakobyan |
| 2 |
[GO] |
2023―Dec―01 |
Immunogenicity of different nanoparticle adjuvants containing recombinant RBD coronavirus antigen in animal model |
Fatemeh Ataei, Ali Ahmadi, Mahdi Fasihi-R, Reza Kachoei, Jafar Amani, Ali Najafi |
| 3 |
[GO] |
2022―Dec―28 |
Design of a multi-epitope based vaccine consisted of immunodominant epitopes of structural proteins of SARS-CoV-2 using immunoinformatics approach |
Shahab Mahmoudvand, Hadi Esmaeili Gouvarchin Ghaleh, Farid Azizi Jalilian, Mahdieh Farzanehpour, Ruhollah Dorostkar |
| 4 |
[GO] |
2022―Oct―31 |
Effect on the conformations of the spike protein of SARS-CoV-2 due to mutation |
Aayatti Mallick Gupta, Jaydeb Chakrabarti |
| 5 |
[GO] |
2022―Jun―01 |
Exploration of potential inhibitors for SARS-CoV-2 Mpro considering its mutants via structure-based drug design, molecular docking, MD simulations, MM/PBSA and DFT calculations |
Abdulrahman Ghasemlou, Vuk Uskoković, Yahya Sefidbakht |
| 6 |
[GO] |
2022―Apr―09 |
The SARS-CoV-2 NSP-2, NSP-12 and Spike partial sequence conservation in stool samples from Abadan, Iran |
Milad Zandi, Saber Soltani, Alireza Tabibzadeh, Sepideh Nasimzadeh, Emad Behboudi, Armin Zakeri, et al. (+3) Yousef Erfani, Shokrollah Salmanzadeh, Samaneh Abbasi |
| 7 |
[GO] |
2021―Dec―29 |
Development of a Recombinant Nucleocapsid Protein-Based ELISA for Detection of IgM and IgG Antibodies to SARS-CoV-2 |
Maryam Ranjbar, Marzieh Asadi, Marjan Nourigorji, Bahador Sarkari, Zohreh Mostafavi-Pour, Kamiar Zomorodian, et al. (+5) Zahra Shabaninejad, Mortaza Taheri-Anganeh, Amir Maleksabet, Mohsen Moghadami, Amir Savardashtaki |
| 8 |
[GO] |
2021―Dec―11 |
Biosensing epidemic and pandemic respiratory viruses: Internet of things with gaussian noise channel algorithmic model |
Subash C.B. Gopinath, Zool Hilmi Ismail, Kazuma Sekiguchi |
| 9 |
[GO] |
2021―Sep―23 |
Stem cell-based and mesenchymal stem cell derivatives for coronavirus treatment |
Zeinab Rafiee, Fereshteh Nejaddehbashi, Ava Nasrolahi, FatemehKhademi Moghadam |
| 10 |
[GO] |
2021―Aug―11 |
Microrna of n-region from Sars-Cov-2: Potential sensing components for biosensor development |
F. Syakirah Halim, N. A Parmin, Uda Hashim, Subash C.B Gopinath, Farrah Aini Dahalan, Iffah Izzati Zakaria, et al. (+2) Wei Chern Ang, N. Fareezah Jaapar |
| 11 |
[GO] |
2021―Jul―10 |
Determination of human COVID-19 total antibodies in serum using a time-resolved fluorescence immunoassay |
Yunjian Xu, Cuicui Chen, Hongrui Lai, Ying He, Guiling Guo, Jianming Feng, Laiqing Li |
| 12 |
[GO] |
2021―May―03 |
Vitamin E at a high dose as an anti- ferroptosis drug and not just a supplement for COVID-19 treatment |
Shima Tavakol, Alexander M. Seifalian |
| 13 |
[GO] |
2021―Apr―02 |
Discovery of Potent Covid-19 Main Protease Inhibitors using Integrated Drug Repurposing Strategy |
T. Muthu Kumar, K. Rohini, Nivya James, V. Shanthi, K. Ramanathan |
| 14 |
[GO] |
2021―Jan―15 |
A comprehensive review of COVID-19 in India: A frequent catch of the information |
Shivangi Shivangi, Laxman S. Meena |
| 15 |
[GO] |
2020―Dec―22 |
Usage of peptidases by SARS-CoV-2 and several human coronaviruses as receptors: A mysterious story |
Somayeh Shatizadeh Malekshahi, Jila Yavarian, Nazanin-Zahra Shafiei-Jandaghi |
| 16 |
[GO] |
2020―Nov―12 |
A review of COVID-19 vaccines and major considerations for diabetic patients |
Saber Soltani, Milad Zandi, Parisa Shiri Aghbash, Masoud Rezaei, Nader Mohammadzadeh, Alireza Afsharifar, Vahdat Poortahmasebi |
| 17 |
[GO] |
2020―Sep―24 |
Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics |
Mona Fani, Milad Zandi, Saber Soltani, Samaneh Abbasi |
